Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Surgical Case Reports|April 22, 2024
Selpercatinib for treating recurrent mixed medullary and follicular cell-derived thyroid carcinoma: a case reportMei Kadoya, Nobuyasu Suganuma, Yuka Matsubara, et al.
Case Reports in Surgery|December 12, 2018
A Large Substernal Goiter that Extended to Both Sides of the ThoraxHirotaka Nakayama, Motohiko Goda, Kaori Kohagura, et al.
Case Reports in Endocrinology|May 26, 2018
A Case of Pneumothorax after Treatment with Lenvatinib for Anaplastic Thyroid Cancer with Lung MetastasisHaruhiko Yamazaki, Hiroyuki Iwasaki, Toshinari Yamashita, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 2, 2017
[Efficacy and Safety of Lenvatinib for Unresectable Anaplastic Thyroid Cancer]Haruhiko Yamazaki, Satoru Shimizu, Hiroyuki Iwasaki, et al.
In Vivo (Athens, Greece)|November 6, 2017
Potential Risk Factors for Nivolumab-induced Thyroid DysfunctionHaruhiko Yamazaki, Hiroyuki Iwasaki, Toshinari Yamashita, et al.
Anticancer Research|February 28, 2023
Validation of EZH2 Inhibitor Efficiency in Anaplastic Thyroid Carcinoma Cell LinesHirotaka Nakayama, Nao Saito, Rika Kasajima, et al.
Endocrine|April 21, 2020
Inflammatory biomarkers and dynamics of neutrophil-to-lymphocyte ratio in anaplastic thyroid carcinomaHaruhiko Yamazaki, Kiminori Sugino, Kenichi Matsuzu, et al.
Case Reports in Endocrinology|December 12, 2018
Nephrectomy for Metastatic Kidney Tumor in Patients with Differentiated Thyroid Cancer: A Report of Two CasesHaruhiko Yamazaki, Takeshi Kishida, Go Noguchi, et al.
Endocrine|December 23, 2019
Sarcopenia is a prognostic factor for TKIs in metastatic thyroid carcinomasHaruhiko Yamazaki, Kiminori Sugino, Kenichi Matsuzu, et al.
Medicine|March 17, 2020
Rapid disease progression after discontinuation of lenvatinib in thyroid cancerHaruhiko Yamazaki, Kiminori Sugino, Kenichi Matsuzu, et al.
Pageof 5